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ABSTRACT 
 
Aim: Hyalinizing Trabecular Tumor (HTT) of the thyroid gland is an unusual and rare follicular 
derived neoplasm, which was first described from Carney and colleagues in 1987. We aim to 
present two cases of HTT diagnosed as papillary thyroid carcinomas in preoperative FNA 
cytological findings, although the postoperative histological examinations revealed the presence of  
Hyalinizing Trabecular tumors. Moreover, a short review regarding the diagnostic and clinical 
aspects of this rare thyroid tumor is also presented. 
Cases Presentation: A 30 year old and a 33 year old females were referred as having papillary 
thyroid carcinomas on preoperative FNA. Total thyroidectomy was offered in both. Histologic 
sections revealed the presence of HTT with the characteristic trabecular arrangement of 
polygonal/spindle cells and positive staining for MIB-1. Both patients remain disease free at a  follow 
up of 5 years. 
Case Study 
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Discussion: Although HTT diagnosis and differentiation from other thyroid tumors remains a topic 
of controversy, immunochemistry and molecular analysis may provide adequate information for HTT 
distinction from papillary thyroid carcinoma (PTC), medullary thyroid cancer (MTC) and 
paragaglioma. Therefore, suspicious cases based on preoperative FNA, require careful evaluation 
and cooperation of pathologists, endocrinologists and endocrine surgeons for optimal diagnosis and 
treatment.  
Conclusions: HTT is a rare, mostly benign neoplasm with favorable prognosis Preoperative 
identification of HTT is significant since its extremely low malignant potential and its favorable 
prognosis may lead to less extended operations and avoidance of postoperative radioiodine 
administration. 
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1. INTRODUCTION 
 
Hyalinizing trabecular tumor of the thyroid gland  
(HTT) is a rare thyroid tumor that was described 
by Carney in 1987 [1]. It is a neoplasm of 
follicular origin and is surrounded by many 
controversial aspects in regards to its diagnosis, 
classification, differential diagnosis and 
malignant potential. In particular, the 
preoperative diagnosis is challenging and its 
accurate classification either as a fully distinct 
entity or as a variant of papillary thyroid 
carcinoma has been a topic of controversy in the 
literature [2,3,4]. Moreover, the differential 
diagnosis from other thyroid neoplasms such as 
Papillary Thyroid Carcinoma (PTC) or Medullary 
Thyroid Carcinoma (MTC) or even 
paraganglioma is difficult as well and relies on 
immunohistochemistry staining methods which 
are also helpful for the differential diagnosis of 
various tumors [5,6]. Nonetheless, the malignant 
potential of the tumors are minimal and most 
reported cases in the literature are benign [7].  
 
2. CASES PRESENTATION  
 
2.1 Case 1  
 
A 30-year-old female was referred with the 
diagnosis of papillary thyroid neoplasm on 
preoperative Fine Needle Aspiration Biopsy 
(FNAB). The preoperative ultrasound revealed a 
11,4 mm solid hypoechoic nodule in the left 
thyroid lobe with high internal vascularity without 
central or lateral lymph node involvement. The 
patient underwent total thyroidectomy.  
 
Histologic sections: Histologic sections revealed 
a well-defined, encapsulated 0.8 cm hyalinizing 
thyroid tumor in a chronic lymphocytic thyroiditis 
background with no evidence of capsular or 
vascular invasion. The tumor cells formatted 
trabecular structures separated by fibrous 
diaphragms with intra-trabecular hyalinization 
[Figs. 1,2]. The nuclei were hyper-chromatic, 
diffusely enlarged with irregular borders and 
occasional pseudoinclusions. Immunochemistry 
of the tumor was positive for thyroglobulin and 
MIB-1 monoclonal antibody, and negative for 
HBME-1 and chromogranine [Fig. 3]. The patient 
was discharged in excellent condition on the first 
postoperative day without any complications. 
One year postoperatively, the patient had no 
signs of recurrence on neck Ultrasound and the 
serum Thyroglobulin levels were also within 
normal levels. Five years postoperatively, the 
patient has no evidence of local recurrence or 
distant metastatic disease. 
 
2.2 Case 2  
 
A 33 years-old female was presented with the 
diagnosis of a 18 mm papillary thyroid carcinoma 
on preoperative FNAB. The preoperative 
ultrasound revealed a hypoechoic nodule with 
well defined borders in the right thyroid lobe. No 
central or lateral lymph node involvement was 
noted. The patient underwent total 
thyroidectomy.  
 
Histologic sections: Histopathological sections 
demonstrated the presence of an Hyalinizing 
Thyroid Tumor with the characteristic trabecular 
arrangement of polygonal and spindle cells 
immersed on an hyaline material. Enlarged oval 
nuclei with inclusions were also found. There 
was no evidence of capsular or vascular 
invasion. Immunohistochemistry was positive for 
thyroglobulin and MIB-1 and negative for 
chromogranine and Collagen IV. The patient was 
discharged on the first postoperative day without 
any complications. At the 1 year follow up, the 
patient exhibited no signs of local recurrence on 
the neck ultrasound and the serum Thyroglobulin 
level was within normal range.  Five years 
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postoperatively, no signs of local recurrence or 
metastatic disease are found.  
 
3. DISCUSSION 
 
Hyalinizing Trabecular Tumor is a rare   
neoplasm of follicular origin which appears 
predominately in middle-aged women. 
Preoperatively, the diagnosis remains 
challenging. In the majority of cases, the 
ultrasonography features are not specific for 
malignancy and the tumor appear as a solid  
hypoechoic lesion with well-defined borders and 
absence of micro-calcifications [8]. In FNA 
smears, the cytologic findings are similar to other 
neoplastic thyroid lesions, such as clear nuclei 
with hyperchromaticity, grooves and pseudo-
inclusions. Currently, permanent histological 
sections and immunohistochemistry offer the 
best chance for a correct diagnosis [4,9]. In 
histologic sections, HTT presents with a 
trabecular growth pattern along with hyalinization 
of the tumor cell cytoplasm. The differential 
diagnosis of this trabecular pattern includes  
PTC, MTC and rare neoplasms like 
paragangliomas. The HTT cells express a unique 
positive MIB-1 staining (a monoclonal antibody 
against Ki-67 antigen) even in FNA biopsy 
smears. Casey et al advise MIB-1 staining in 
cases of aspirates which are hypocellular, not 
bloody or both, with an unexpectedly large 
number of nuclear grooves and/or inclusions and 
when hyaline material is sparse or absent. 
However, that positive stain is not found in      
PTC cells [10]. Additionally, the absence of 
BRAF and RAS mutations and the                
weak expression of CK19 and galectin-3 markers 
in HTT patients [11] offer another point of 
distinction from PTC. Finally, HTT can be 
differentiated from MTC by stain negative for 
calcitonin. The malignant potential of HTT is 
extremely rare and only few cases have        
been described to be carcinomas. In the largest 
series with 119 HTT patients, only one had 
vascular/capsular invasion and pulmonary 
metastasis [7]. Given these considerations, in   
our series the follow-up management      
paradigm has moved away from diagnostic 
whole body RAI scanning and toward a      
greater reliance on neck ultrasonography         
and serial serum Tg measurements. At the          
1 year follow up, neck ultrasound performed       
by an experienced radiologist and      
thyroglobulin measurement failed to detect       
any sign of local/locoregional or distant 
metastasis.   
 
 
Fig. 1. Trabecular structures separated by 
fibrous diaphragms with intra-trabecular 
hyalinization 
 
 
 
Fig. 2. Hyper-chromatic nuclei, diffusely 
enlarged, with irregular borders and 
occasionally pseudo-inclusions 
 
 
 
Fig. 3. MIB-1 staining showed a distinctive 
membranous pattern 
4. CONCLUSION 
 
HTT is a rare, mostly benign neoplasm with 
favorable prognosis. The preoperative diagnosis 
and differentiation from other thyroid neoplasms 
and especially PTC remains challenging. 
Permanent histologic sections with 
  
 
 
Kiriakopoulos et al.; IJMPCR, 9(1): 1-4, 2017; Article no.IJMPCR.33912 
 
 
 
4 
 
immunochemistry and molecular analysis provide 
definite information for HTT recognition and 
distinction from PTC, MTC and paraganglioma. 
Given its favorable prognosis, in case of 
preoperative FNA findings suggestive for a HTT 
tumor on MIB-1 staining, a less aggressive 
treatment is warranted. 
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